Image source: © 2025 Krish Capital Pty.Ltd

Highlights

  • Wall Street Zen upgraded RELX from “Hold” to “Buy” in latest rating shift
  • Morgan Stanley reaffirmed its “Overweight” stance on RELX in April 2025
  • Consensus rating stands at “Buy” based on multiple analyst recommendations

RELX Plc (NYSE: RELX) has received a fresh round of positive sentiment from equities research analysts, as Wall Street Zen upgraded its rating from “Hold” to “Buy” in a report released on Saturday. The move adds to existing support for the company’s shares, with Morgan Stanley having reaffirmed an “Overweight” rating in a research note dated April 16, 2025. In total, five analysts currently rate the stock as a “Buy,” while one has issued a “Strong Buy,” leading to a consensus rating of “Buy,” according to MarketBeat.com.

Investor activity has also remained strong. Commonwealth Equity Services LLC increased its holdings by 11.0 percent during the fourth quarter, while American Century Companies Inc. and Sei Investments Co. raised their positions by 5.1 percent and 3.8 percent, respectively. LPL Financial LLC grew its holdings by 20.9 percent, and Congress Wealth Management LLC DE added to its position with an 8.7 percent increase. Overall, institutional investors now hold approximately 15.02 percent of the company’s outstanding shares.

RELX operates across four main business segments—Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The company delivers data and analytics tools to help professionals in healthcare, science, and legal sectors enhance performance and outcomes.

The revised ratings and increased institutional holdings suggest heightened interest from both analysts and professional investors as the company navigates 2025.